Joint Corp. (JYNT)

In the past six months, The Joint Corp. reported Q4 2025 and full-year financial results, appointed Ron Stilwell, signed an Asset Purchase Agreement for Southeast Clinics, reported Q3 2025 financial results, reported Q1 2026 financial results, signed an Asset Purchase Agreement for Southern California Clinics, appointed Michelle Reap as Director of Franchise Development, and had an insider buying report. The stock price as of May 1, 2026, was $8.90 per share, representing a decline of 15.20% from May 2, 2025.

Specific details about the demand seasonality for The Joint Corp.'s products and services are not provided. The company's business model suggests a potential for consistent demand, but specific seasonal fluctuations are not explicitly outlined.

The Joint Corp. operates in the Medical - Care Facilities industry, providing accessible, affordable, and convenient chiropractic care through a cash-based, membership model. The company offers chiropractic adjustments, wellness care, pain management solutions, sports injury management, and preventive health care. They also provide franchise development and support to their franchisees.

The Joint Corp. has over 950 locations across 43 states as of April 2026, focusing on expanding its network through franchising. As of March 31, 2026, there were 943 total clinics in operation, consisting of 868 franchised clinics and 75 company-owned or managed clinics. The company is actively pursuing a refranchising strategy, including selling corporate-owned clinics.

The Joint Corp. generally maintains a positive brand reputation within the chiropractic industry, receiving recognition and awards. However, older information from April 2022 indicates that the company has faced lawsuits and customer complaints regarding issues such as overbilling, misconduct, and difficulty with subscription cancellations.

The Joint Corp. has significant institutional ownership, with 76.88% of the stock held by institutions. Insiders hold 30.20% of the company's stock, and over the last three months, insiders have purchased a net of $139,139.00 in company stock.